Farid Menaa has completed his PhD with Summa Cum Laude in 2003 from French Energy Atomic Authority (CEA/CEN-Paris), French Ministry of Defense, and postdoctoral studies from Sidney Kimmel Cancer Center/Sanford-Burnham Medical Research Institute-USA (2004-2007, Oncology), University of Wurzburg-Germany (2007-2009, Dermatology and Stem Cells), Unicamp-Brazil (2010-2012). He is international consultant in cancer Nano medicine, gerontology, cosmetology, food nanotechnology and regenerative medicine. He is also the executive Director of Fluorotronics, Inc., a chemical and nanotech company, and co-pioneered the Carbone-Fluorine related analytical methods for biomedical and pharmaceutical (nano-) applications. He has published numerous papers, serves as an editorial board member in reputed journals, and co-organized several international events on Nano medicine and Nanobiotechnology.
Nano medicine, Nanobiotechnology, Food Nanotechnology, Cosmetology and Regenerative Medicine.